Michael G. Spelios

Circulating Differentially Methylated Amylin DNA as a Biomarker of β-Cell Loss in Type 1 Diabetes

John A. Olsen, Lauren A. Kenna, Michael G. Spelios et al. · PLoS ONE · 2016 · 52 citations · Full text

Type 1, Epigenetic Regulation, Medicine +15

A Minimally-invasive Blood-derived Biomarker of Oligodendrocyte Cell-loss in Multiple Sclerosis

John A. Olsen, Lauren A. Kenna, Regine C. Tipon et al. · EBioMedicine · 2016 · 34 citations · Full text

β-Cell death is decreased in women with gestational diabetes mellitus

Lauren A. Kenna, John A. Olsen, Michael G. Spelios et al. · Diabetology & Metabolic Syndrome · 2016 · 27 citations · Full text

Physicochemical properties affecting lipofection potency of a new series of 1,2-dialkoylamidopropane-based cationic lipids

Ahmad Aljaberi, Michael G. Spelios, Molinda Kearns et al. · Colloids and Surfaces B Biointerfaces · 2007 · 25 citations · Full text

Lipid Preparation, Medicinal Chemistry, Lipofection Potency +6

In Vitro Lipofection with Novel Asymmetric Series of 1,2-Dialkoylamidopropane-Based Cytofectins Containing Single Symmetric Bis-(2-dimethylaminoethane) Polar Headgroups

Michalakis Savva, Pensung Chen, Ahmad Aljaberi et al. · Bioconjugate Chemistry · 2005 · 23 citations

Lipid Preparation, Medicinal Chemistry, Novel Asymmetric Series +14